ADCYAP1 and Parkinson disease: It has been depicted that PACAP markedly declines the DArgic nerve cell deprivation provoked by 6-OHDA exposure, upgrades behavioral impairment [202], de-escalates the fundamental manifestation of PD (hypokinesia) [203], and slows the decline in DA content.